United States Considers Peptide Reclassification
A regulatory update announced in February 2026 could impact the advancement of peptide-based therapies in the United States. HHS Secretary Robert F. Kennedy Jr. stated that the U.S. Food and Drug Administration is considering moving 14 peptides currently classified under Category 2 to Category 1 within its regulatory system. If confirmed, the change would allow […]
The Rise of Peptides: The Breakthrough Redefining the New Standard of Health
We Live in a New Era We are living in a new era. The growing interest in better health, performance, and longevity is increasingly shifting from being a trend to becoming the dominant behavior of the 21st-century population. Never before has there been so much talk about science applied to well-being — and never before […]